Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity

Molecular and Cellular Biochemistry

Volumn 351, Issue 1-2, 2011, Pages 125-131

  Atalay, Mustafa ^a   Bilginoglu, Ayca ^b   Kokkola, Tarja ^a   Oksala, Niku ^c   Turan, Belma ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ANKARA UNIVERSITY   (Turkey)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Liver; Oxidative stress; Oxygen radical absorbance capacity; Protein carbonyls; Protein thiols; Skeletal muscle; Thioredoxin 1

Indexed keywords

CARBONYL DERIVATIVE; DOXYCYCLINE; OXYGEN RADICAL; SELENATE; THIOREDOXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; LIVER; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TREATMENT DURATION; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DOXYCYCLINE; LIVER; MALE; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SELENIUM COMPOUNDS; STREPTOZOCIN; THIOREDOXINS;

RATTUS;

EID: 79953687940     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0719-3     Document Type: Article

References (44)

1. Nishinaka Y, Nakamura H, Masutani H, Yodoi J (2001) Redox control of cellular function by thioredoxin; a new therapeutic direction in host defence. Arch Immunol Ther Exp (Warsz) 49:285-292 (Pubitemid 33612109)
2. Atalay M, Laaksonen DE, Niskanen L, Uusitupa M, Hänninen O, Sen CK (1997) Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stres. Acta Physiol Scand 161:195-201 (Pubitemid 27445703)
3. Atalay M, Laaksonen DE (2002) Diabetes, oxidative stress and physical exercise. J Sport Sci Med 1:1-14
4. Jones DP (2008) Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 295:C849-C868
5. Cantin AM, Hubbard RC, Crystal RG (1989) Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139:370-372 (Pubitemid 19057410)
6. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101:1833-1839 (Pubitemid 30213106)
7. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase- 2. Circulation 112:544-552 (Pubitemid 41060795)
8. Lemaitre V, D'armiento J (2006) Matrix metalloproteinases in development and disease. Birth Defects Res C 78:1-10
9. Arnér ES, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420-426 (Pubitemid 44780139)
10. Berggren M, Gallegos A, Gasdaska J, Powis G (1997) Cellular thioredoxin reductase activity is regulated by selenium. Anti-cancer Res 17:3377-3380 (Pubitemid 27522297)
11. Berggren MM, Mangin JF, Gasdaka JR, Powis G (1999) Effect of selenium on rat thioredoxin reductase activity: increase by supranutritional selenium and decrease by selenium deficiency. Biochem Pharmacol 57:187-193 (Pubitemid 29056180)
12. Yamawaki H, Berk BC (2005) Thioredoxin: a multifunctional antioxidant enzyme in kidney, heart and vessels. Curr Opin Nephrol Hypertens 14:149-153 (Pubitemid 40396868)
13. Kakisaka Y, Nakashima T, Sumida Y, Yoh T, Nakamura H, Yodoi J, Senmaru H (2002) Elevation of serum thioredoxin levels in patients with type 2 diabetes. Hom Metab Res 34:160-164 (Pubitemid 34293275)
14. Miyamoto S, Kawano H, Hokamaki J, Soejima H, Kojima S, Kudoh T, Nagayoshi Y, Sugiyama S, Sakamoto T, Yoshimura M, Nakamura H, Yodoi J, Ogawa H (2005) Increased plasma levels of thioredoxin in patients with glucose intolerance. Intern Med 44:1127-1132
15. Hokamaki J, Kawano H, Soejima H, Miyamoto S, Kajiwara I, Kojima S, Sakamoto T, Sugiyama S, Yoshimura M, Nakamura H, Yodoi J, Ogawa H (2005) Plasma thioredoxin levels in patients with unstable angina. Int J Cardiol 99:225-231 (Pubitemid 40320794)
16. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B (2004) Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys 426:83-90 (Pubitemid 38595133)
17. Can B, Ulusu NN, Kilinç K, Leyla Acan N, Saran Y, Turan B (2005) Selenium treatment protects diabetes-induced biochemical and ultrastructural alterations in liver tissue. Biol Trace Elem Res 105:135-150 (Pubitemid 41009053)
18. Berg EA, Wu JY, Campbell L, Kagey M, Stapleton SR (1995) Insulin-like effects of vanadate and selenate on the expression of glucose-6-phosphate dehydrogenase and fatty acid synthase in diabetic rats. Biochimie 77:919-924
19. Yaras N, Sariahmetoglu M, Bilginoglu A, Aydemir-Koksoy A, Onay-Besikci A, Turan B, Schulz R (2008) Protective action of doxycycline against diabetic cardiomyopathy in rats. Br J Pharmacol 155:1174-1184
20. Golub LM, Ramamurthy N, McNamara T, Greenwald R, Rifkin B (1991) Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2:297-322
21. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T (1998) Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26
22. Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Wang KY, Lai HC, Liu TJ (2007) Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969-980
23. Soory M (2008) A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2:5-12
24. Lappalainen Z, Lappalainen J, Oksala NKJ, Laaksonen DE, Khanna S, Sen CK, Atalay M (2009) Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain. J Appl Physiol 106:461-467
25. Prior RL, Hoang H, Gu L, Wu X, Bacchiocca M, Howard L, Hampsch-Woodill M, Huang D, Ou B, Jacob R (2003) Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 51:3273-3279
26. Kinnunen S, Hyyppä S, Lehmuskero A, Oksala N, Mäenpää P, Hänninen O, Atalay M (2005) Oxygen radical absorbance capacity (ORAC) and exercise-induced oxidative stress in trotters. Eur J Appl Physiol 95:1-7
27. Oksala NK, Paimela H, Alhava E, Atalay M (2007) Heat shock preconditioning induces protein carbonylation and alters antioxidant protection in superficially injured guinea pig gastric mucosa in vitro. Dig Dis Sci 52:1897-1905 (Pubitemid 47024651)
28. Turan B, Desilets M, Acan LN, Hotomaroglu O, Vannier C, Vassort G (1996) Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc Res 32:351-361 (Pubitemid 26246882)
29. Jotty K, Ojeda ML, Nogales F, Rubio JM, Murillo ML, Carreras O (2009) Selenium tissue distribution changes after ethanol exposure during gestation and lactation: selenite as a therapy. Food Chem Toxicol 47(10):2484-2489
30. Gan L, Liu Q, Xu HB, Zhu YS, Yang XL (2002) Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biol Trace Elem Res 89(2):165-175 (Pubitemid 35283707)
31. Cao G, Shukitt-Hale B, Bickford PC, Joseph JA, McEwen J, Prior RL (1999) Hyperoxia-induced changes in antioxidant capacity and the effect of dietary antioxidants. J Appl Physiol 86:1817-1822 (Pubitemid 29275553)
32. Shacter E (2000) Quantification and significance of protein oxidation samples. Drug Metab Rev 32:307-326
33. Stadtman ER, Levine RL (2000) Protein oxidation. Ann N Y Acad Sci 899:191-208 (Pubitemid 30352787)
34. Telci A, Cakatay U, Salman S, Satman I, Sivas A (2000) Oxidative protein damage in early stage type 1 diabetic patients. Diabetes Res Clin Pract 50:213-223
35. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000) Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26:163-176 (Pubitemid 30435761)
36. to remodeling in diabetic rat heart. Am J Physiol Heart Circ Physiol 288:H1417-H1424
37. Kiersztan A, Baranska A, Hapka M, Lebiedzinska M, Winiarska K, Dudziak M, Bryla J (2009) Differential action of methyselenocysteine in control and alloxan-diabetic rabbits. Chem Biol Interact 27:161-171
38. Hawkes WC, Alkan Z (2010) Regulation of redox signaling by selenoproteins. Biol Trace Elem Res 134:235-251
39. Ulusu NN, Turan B (2005) Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol Trace Elem Res 103:207-216
40. Tuncay E, Seymen AA, Tanriverdi E, Yaras N, Tandogan B, Ulusu NN, Turan B (2007) Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol Cell Biochem 304:255-263 (Pubitemid 47456874)
41. Ayaz M, Ozdemir S, Yaras N, Vassort G, Turan B (2005) Selenium- induced alterations in ionic currents of rat cardiomyocytes. Biochem Biophys Res Commun 327:163-173; Erratum in: Biochem Biophys Res Commun 329:418
42. Selenius M, Fernandes AP, Brodin O, Björnstedt M, Rundlöf AK (2008) Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system. Biochem Pharmacol 75:2092-2099
43. Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM, Rifkin BR (1993) Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 8:1247-1253 (Pubitemid 23308119)
44. Ryan ME, Ramamurthy NS, Golub LM (1998) Tetracyclines inhibit protein glycation in experimental diabetes. Adv Dent Res 12:152-158